国: アイルランド
言語: 英語
ソース: HPRA (Health Products Regulatory Authority)
MARBOFLOXACIN
LAVET Pharmaceuticals Ltd
QJ01MA93
MARBOFLOXACIN
5 mg/tablet
Tablets Chewable
POM
Canine, Feline
Marbofloxacin
Antibacterial
Authorised
2013-02-22
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE VETERINARY MEDICINAL PRODUCT Marboxidin 5 mg Chewable Tablets for Dogs and Cats. 2 QUALITATIVE AND QUANTITATIVE COMPOSITION 3 PHARMACEUTICAL FORM Chewable tablet. Brownish, oval, divisible, centre scored chewable tablets. The tablets can be divided into equal halves. 4 CLINICAL PARTICULARS 4.1 TARGET SPECIES Dogs and cats. 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES In dogs Marbofloxacin is indicated in the treatment of: • skin and soft tissue infections (skinfold pyoderma, impetigo, folliculitis, furunculosis, cellulitis) caused by strains of microorganisms susceptible to marbofloxacin_;_ • urinary tract infections (UTI) associated or not with prostatitis or epididymitis caused by strains of microorganisms susceptible to marbofloxacin_;_ • respiratory tract infections caused by strains of microorganisms susceptible to marbofloxacin_._ In cats Marbofloxacin is indicated in the treatment of skin and soft tissue infections (wounds, abscesses, phlegmons) and upper respiratory tract infections caused by strains of microorganisms susceptible to marbofloxacin. 4.3 CONTRAINDICATIONS Do not use in dogs aged less than 12 months, or less than 18 months for exceptionally large breeds of dogs, such as Great Danes, Briard, Bernese, Bouvier and Mastiffs, with a longer growth period. Not recommended for use in cats aged less than 16 weeks. Do not use in animals with known hypersensitivity to marbofloxacin or other (fluoro)quinolones. 4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES A low urinary pH could have an inhibitory effect on the activity of marbofloxacin. Each tablet contains: ACTIVE SUBSTANCE: Marbofloxacin 5 mg EXCIPIENTS: For a full list of excipients, see section 6.1 IRISH MEDICINES BOARD ________________________________________________________ 完全なドキュメントを読む